Naito K - Search Results

1

Gain of 5p15.33 is associated with progression of bladder cancer.

Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K. Yamamoto Y, et al. Among authors: naito k. Oncology. 2007;72(1-2):132-8. doi: 10.1159/000111132. Epub 2007 Nov 15. Oncology. 2007. PMID: 18025801

2

Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.

Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K. Yamamoto Y, et al. Among authors: naito k. Clin Cancer Res. 2004 Oct 1;10(19):6449-55. doi: 10.1158/1078-0432.CCR-04-0773. Clin Cancer Res. 2004. PMID: 15475431

3

Biological characteristics in bladder cancer depend on the type of genetic instability.

Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Among authors: naito k. Clin Cancer Res. 2006 May 1;12(9):2752-8. doi: 10.1158/1078-0432.CCR-05-0805. Clin Cancer Res. 2006. PMID: 16675567

4

Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.

Yamamoto Y, Matsuyama H, Kawauchi S, Matsumoto H, Nagao K, Ohmi C, Sakano S, Furuya T, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Among authors: naito k. Oncology. 2006;70(3):231-7. doi: 10.1159/000094416. Epub 2006 Jul 6. Oncology. 2006. PMID: 16837776

5

Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.

Akao J, Matsuyama H, Yamamoto Y, Sasaki K, Naito K. Akao J, et al. Among authors: naito k. Clin Cancer Res. 2006 Dec 1;12(23):7004-8. doi: 10.1158/1078-0432.CCR-06-0825. Clin Cancer Res. 2006. PMID: 17145821

6

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.

Yamamoto Y, Matsuyama H, Chochi Y, Okuda M, Kawauchi S, Inoue R, Furuya T, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Among authors: naito k. Cancer Genet Cytogenet. 2007 Apr 1;174(1):42-7. doi: 10.1016/j.cancergencyto.2006.11.012. Cancer Genet Cytogenet. 2007. PMID: 17350465

7

Clinical significance of allelic loss of chromosome region 5q22.3 approximately q23.2 in nonpapillary renal cell carcinoma.

Nagao K, Yoshihiro S, Matsuyama H, Yamaguchi S, Oba K, Naito K. Nagao K, et al. Among authors: naito k. Cancer Genet Cytogenet. 2002 Jul 1;136(1):23-30. doi: 10.1016/s0165-4608(02)00511-3. Cancer Genet Cytogenet. 2002. PMID: 12165447

8

Renal cell carcinoma: allelic loss at chromosome 9 using the fluorescent multiplex-polymerase chain reaction technique.

Fukunaga K, Wada T, Matsumoto H, Yoshihiro S, Matsuyama H, Naito K. Fukunaga K, et al. Among authors: naito k. Hum Pathol. 2002 Sep;33(9):910-4. doi: 10.1053/hupa.2002.126877. Hum Pathol. 2002. PMID: 12378516

9

Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.

Matsuyama H, Pan Y, Yoshihiro S, Kudren D, Naito K, Bergerheim US, Ekman P. Matsuyama H, et al. Among authors: naito k. Prostate. 2003 Feb 1;54(2):103-11. doi: 10.1002/pros.10173. Prostate. 2003. PMID: 12497583

10

Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.

Matsumoto H, Wada T, Fukunaga K, Yoshihiro S, Matsuyama H, Naito K. Matsumoto H, et al. Among authors: naito k. Jpn J Clin Oncol. 2004 Mar;34(3):124-30. doi: 10.1093/jjco/hyh026. Jpn J Clin Oncol. 2004. PMID: 15078907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,441 results

Search Page

Filters